1. Home
  2. STN vs IOVA Comparison

STN vs IOVA Comparison

Compare STN & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stantec Inc

STN

Stantec Inc

N/A

Current Price

$72.21

Market Cap

7.5B

ML Signal

N/A

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

N/A

Current Price

$8.34

Market Cap

6.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
STN
IOVA
Founded
1954
2007
Country
Canada
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.5B
6.7B
IPO Year
2005
2008

Fundamental Metrics

Financial Performance
Metric
STN
IOVA
Price
$72.21
$8.34
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
★ $14.40
AVG Volume (30 Days)
270.0K
★ 12.3M
Earning Date
11-12-2026
11-05-2026
Dividend Yield
★ 0.95%
N/A
EPS Growth
N/A
★ 14.84
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$8.97
$56.63
Revenue Next Year
$5.63
$43.83
P/E Ratio
$28.96
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$65.35
$1.76
52 Week High
$111.02
$15.37

Technical Indicators

Market Signals
Indicator
STN
IOVA
Relative Strength Index (RSI) 60.72 29.97
Support Level $71.90 $7.85
Resistance Level $73.03 $9.36
Average True Range (ATR) 1.57 0.98
MACD 0.49 -0.75
Stochastic Oscillator 87.77 1.76

Price Performance

Historical Comparison
STN
IOVA

About STN Stantec Inc

Stantec Inc is a sustainable engineering, architecture, and environmental consulting company. It offers services through the following business operating units; Environmental Services, Infrastructure, Water, Buildings, and Energy & Resources. Maximum revenue is derived from its Infrastructure business unit, which is engaged in evaluating, planning, and designing infrastructure solutions for transportation, community development, and urban spaces. The company's reportable segments are the United States, which derives maximum revenue, Canada, and Global. These segments provide consulting in engineering, architecture, interior design, landscape architecture, surveying, environmental sciences, project management, and project economics services in the area of infrastructure and facilities.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

Share on Social Networks: